June 2022

Folate receptor α may be an important treatment target for ovarian tumors.

Breast cancer screening guidelines using mammography vary among guiding bodies, including the American Cancer Society and the American Academy of Family Physicians.

Simplifying processes reduces errors in compounding, IV pump programming, and physician order entry.

PAPs can significantly reduce OOP costs for patients.

The treatment landscape for relapsed/refractory MZL and follicular lymphoma (FL) is shifting from intravenous chemotherapy and monoclonal antibodies to oral oncolytic therapy or CD19-directed chimeric antigen receptor (CAR) T-cell therapy.

A patient with CLL relies on his pharmacy team for support.

Biosimilar therapeutic interchange processes can mitigate high costs of cancer drugs.

The efforts of pharmacists remain critical to the success of treatment outcomes.

Oncology pharmacists can help ensure patient access to lifesaving therapies.